Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ACTU will decline by -20.31% over the next 2 Weeks and hit $0.77 by Wednesday, August 26, 2026. In that time frame, ACTU's share price is expected to range between $0.58 and $0.96.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 26, 2026 | 0.58 | 0.77 | 0.96 |
| Aug 25, 2026 | 0.61 | 0.80 | 0.99 |
| Aug 24, 2026 | 0.58 | 0.76 | 0.93 |
| Aug 21, 2026 | 0.60 | 0.78 | 0.96 |
| Aug 20, 2026 | 0.70 | 0.89 | 1.07 |
| Aug 19, 2026 | 0.69 | 0.88 | 1.06 |
| Aug 18, 2026 | 0.72 | 0.90 | 1.07 |
| Aug 17, 2026 | 0.68 | 0.87 | 1.05 |
| Aug 14, 2026 | 0.72 | 0.89 | 1.07 |
| Aug 13, 2026 | 0.82 | 1.00 | 1.17 |
ACTU shares fell -1.25% in Thursday, August 13, 2026's trading session, dropping from a previous close of $0.98 to move at $0.97. The stock demonstrated notable intraday movement (see ACTU's key stats for a full breakdown), fluctuating between $0.95 and $0.98, a +3.37% trading range. While recent weeks have seen some volatility, ACTU has managed to secure a -17.30% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 206.5K shares changing hands, 109.65K fewer than the previous session. This amounted to $199.81K in total market activity.
Will ACTU Continue Its Downward Trend?
According to analyst ratings and projections for ACTU, Actuate Therapeutics Inc shares are anticipated to decrease by -1.03%, potentially reaching $0.96 per share by August 26, 2026. Short-term technical indicators currently suggest a neutral sentiment for ACTU. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the ACTU stock forecast, now is not the best time to buy ACTU stock because its current trading price is +25.19% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ACTU covering social and institutional perspectives.
ACTU Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ACTU's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.19% to 35.68%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 38.72%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 41.59%, maintains a neutral outlook for the long term. Insights into ACTU's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Actuate Therapeutics Short-Term Forecasts
ACTU Forecast For Next 5 Days
Our algorithm anticipates Actuate Therapeutics (ACTU) stock could hit $0.83 by Aug 20, 2026. This represents a -14.56% fall from today's price, following a -3.30% change over the past five days.
ACTU Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Actuate Therapeutics Inc (ACTU) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.67, which would mean a -30.76% decrease from the current price of $0.97. Projections for this period range from a high of $1.10 to a low of $0.37.
ACTU Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Actuate Therapeutics's price over the next three months point to a rise. ACTU stock is expected to peak at $2.72 on Aug 21, 2026 before potentially dipping to $0.94 on Oct 29, 2026. On average, ACTU is likely to trade around $1.78 in the coming 90 days.
Actuate Therapeutics Stock Forecast 2025
Based on our predictive models, Actuate Therapeutics (ACTU) is expected to trade between $0.76 and $2.72 throughout 2026. This would result in an average price of $1.59, potentially offering investors a +64.32% return from current levels.
Actuate Therapeutics Inc Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Actuate Therapeutics Inc (ACTU) is positioned to show a strong performance in August 2026. The price is predicted to move between $2.22 and $2.72, settling at an average of $2.53. This could translate to a +161.47% gain.
September 2026
Based on current market signals, Actuate Therapeutics Inc is projected to trend september 2026. We forecast a trading range from $1.48 to $2.40, with a likely average price of $1.87. Investors could expect a potential return of +93.26%.
October 2026
Our predictive algorithms indicate Actuate Therapeutics Inc stock may see a shift in October 2026. The expected range spans $0.94–$2.06, with an average target of $1.52. This represents a positive outlook and a possible gain of +57.09%.
November 2026
Analyzing established trends, Actuate Therapeutics Inc looks set to move in November 2026. Projections place the stock between $0.97 and $1.49, averaging around $1.25. This suggests a +29.19% gain from current levels.
December 2026
Market indicators suggest Actuate Therapeutics Inc could experience notable changes during December 2026. Prices could fluctuate within $0.76 to $1.45, with a midpoint forecast of $1.17. The stock might deliver a +20.92% gain.
January 2027
Forecasting for January 2027, models estimate that Actuate Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $0.40 and $0.94, averaging $0.64. This signals a cautious trajectory with potential returns around -33.86%.
February 2027
According to our latest forecast models, Actuate Therapeutics Inc (ACTU) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.23 and $0.57, settling at an average of $0.39. This could translate to a -59.69% loss.
March 2027
Based on current market signals, Actuate Therapeutics Inc is projected to trend march 2027. We forecast a trading range from $0.00 to $0.47, with a likely average price of $0.20. Investors could expect a potential return of -79.33%.
April 2027
Our predictive algorithms indicate Actuate Therapeutics Inc stock may see a shift in April 2027. The expected range spans $0.02–$0.36, with an average target of $0.20. This represents a cautious outlook and a possible loss of -79.33%.
May 2027
Analyzing established trends, Actuate Therapeutics Inc looks set to move in May 2027. Projections place the stock between $0.03 and $0.36, averaging around $0.21. This suggests a -78.30% loss from current levels.
June 2027
Market indicators suggest Actuate Therapeutics Inc could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $0.25, with a midpoint forecast of $0.11. The stock might deliver a -88.63% loss.
July 2027
Forecasting for July 2027, models estimate that Actuate Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.21, averaging $0.08. This signals a cautious trajectory with potential returns around -91.73%.
August 2027
According to our latest forecast models, Actuate Therapeutics Inc (ACTU) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.20, settling at an average of $0.07. This could translate to a -92.77% loss.
ACTU's history of dividends and stock splits also plays a role in long-term investor confidence.